1. Home
  2. YDES vs HPP Comparison

YDES vs HPP Comparison

Compare YDES & HPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YDES
  • HPP
  • Stock Information
  • Founded
  • YDES 2013
  • HPP 1997
  • Country
  • YDES Taiwan
  • HPP United States
  • Employees
  • YDES N/A
  • HPP N/A
  • Industry
  • YDES
  • HPP Real Estate
  • Sector
  • YDES
  • HPP Finance
  • Exchange
  • YDES Nasdaq
  • HPP Nasdaq
  • Market Cap
  • YDES 1.1B
  • HPP 940.3M
  • IPO Year
  • YDES N/A
  • HPP 2010
  • Fundamental
  • Price
  • YDES $12.51
  • HPP $2.35
  • Analyst Decision
  • YDES
  • HPP Hold
  • Analyst Count
  • YDES 0
  • HPP 11
  • Target Price
  • YDES N/A
  • HPP $3.04
  • AVG Volume (30 Days)
  • YDES 46.8K
  • HPP 3.6M
  • Earning Date
  • YDES 09-30-2025
  • HPP 11-05-2025
  • Dividend Yield
  • YDES N/A
  • HPP N/A
  • EPS Growth
  • YDES N/A
  • HPP N/A
  • EPS
  • YDES N/A
  • HPP N/A
  • Revenue
  • YDES $510,360.00
  • HPP $792,977,000.00
  • Revenue This Year
  • YDES N/A
  • HPP N/A
  • Revenue Next Year
  • YDES N/A
  • HPP $6.87
  • P/E Ratio
  • YDES N/A
  • HPP N/A
  • Revenue Growth
  • YDES 45.76
  • HPP N/A
  • 52 Week Low
  • YDES $5.30
  • HPP $1.78
  • 52 Week High
  • YDES $25.00
  • HPP $4.67
  • Technical
  • Relative Strength Index (RSI)
  • YDES N/A
  • HPP 31.10
  • Support Level
  • YDES N/A
  • HPP $2.53
  • Resistance Level
  • YDES N/A
  • HPP $2.63
  • Average True Range (ATR)
  • YDES 0.00
  • HPP 0.11
  • MACD
  • YDES 0.00
  • HPP -0.02
  • Stochastic Oscillator
  • YDES 0.00
  • HPP 7.25

About YDES YD Bio Limited Ordinary Shares

YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.

About HPP Hudson Pacific Properties Inc.

Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.

Share on Social Networks: